<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="application/xml; charset=UTF-8">
<title>input-de</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel">Verordnung<br>über die Meldestelle für lebenswichtige Humanarzneimittel</h1>
<p class="erlassdatum man-space-before-3">vom 28. Mai 2025 (Stand am 1. Juli 2025)</p>
</div>
<div id="preamble"><div>
<p class="man-template-autor man-space-before-10">Der Schweizerische Bundesrat,</p>
<p class="ingress man-space-before-3">gestützt auf Artikel 57 Absatz 1 des Landesversorgungsgesetzes vom 17. Juni 2016<sup><a href="#fn-d7e16" id="fnbck-d7e16">1</a></sup>,</p>
<p class="man-template-verb man-space-before-3 man-space-after-18">verordnet:</p>
<div class="footnotes"><p id="fn-d7e16"><sup><a href="#fnbck-d7e16">1</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2017/308" target="_blank">SR <b>531</b></a></p></div>
</div></div>
<main id="maintext"><section id="sec_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_1">1. Abschnitt:  Meldestelle</a>
</h1>
<div class="collapseable"><article id="art_1"><a name="a1"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_1"><b>Art. 1</b></a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4"><sup>1</sup> Der Fachbereich Heilmittel der Organisation der wirtschaftlichen Landesversorgung betreibt zur Sicherstellung der Versorgung des Landes mit lebenswichtigen Humanarzneimitteln eine Meldestelle.</p>
<p class="absatz man-space-before-4"><sup>2</sup> Als lebenswichtig gelten vom Schweizerischen Heilmittelinstitut zugelassene Humanarzneimittel:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">die nicht oder nur eingeschränkt ersetzbar sind; und</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">deren Fehlen über längere Zeit gravierende gesundheitliche Folgen hätte.</dd>
</dl>
</div></article></div></section><section id="sec_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_2">2. Abschnitt:  Meldung</a>
</h1>
<div class="collapseable">
<article id="art_2"><a name="a2"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_2"><b>Art. 2</b> Meldepflicht</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4"><sup>1</sup> Die Inhaberinnen der Zulassung eines Humanarzneimittels, das einen im Anhang aufgeführten Wirkstoff enthält, müssen der Meldestelle sowohl voraussehbare als auch nicht voraussehbare Versorgungsengpässe oder Lieferunterbrüche von lebenswichtigen Humanarzneimitteln melden, sofern der Engpass oder Unterbruch voraussichtlich mehr als vierzehn Tage dauert. </p>
<p class="absatz man-space-before-4"><sup>2</sup> Sie müssen melden, welche Dosierungsstärke einer Darreichungsform betroffen ist und wann diese voraussichtlich wieder lieferbar ist.</p>
<p class="absatz man-space-before-4"><sup>3</sup> Nicht gemeldet werden müssen Versorgungsengpässe oder Lieferunterbrüche, wenn lediglich die Packungsgrösse einer bestimmten Dosierungsstärke einer Darreichungsform betroffen ist und diese durch eine andere Packungsgrösse ersetzt werden kann.</p>
<p class="absatz man-space-before-4"><sup>4</sup> Die Meldungen müssen innerhalb von fünf Arbeitstagen, nachdem die Zulassungsinhaberin Kenntnis vom Versorgungsengpass oder Lieferunterbruch erhalten hat, erfolgen.</p>
</div></article><article id="art_3"><a name="a3"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_3"><b>Art. 3</b> Inhalt und Form der Meldung</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4"><sup>1</sup> Die Zulassungsinhaberin muss insbesondere Folgendes melden:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">Name und Adresse sowie eine Ansprechperson;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">Zulassungsnummer und Handelsnummer des Humanarzneimittels;</dd>
<dt class="man-space-before-4">c. </dt>
<dd class="man-space-before-4">genaue Bezeichnung des Humanarzneimittels, einschliesslich Wirkstoff, Darreichungsform, Dosierung und Packungsgrösse;</dd>
<dt class="man-space-before-4">d. </dt>
<dd class="man-space-before-4">Sachverhalt, einschliesslich Ursachen, betroffener Stellen im In- und Ausland, aktueller Lagerbestände und historischer sowie erwarteter Absätze;</dd>
<dt class="man-space-before-4">e. </dt>
<dd class="man-space-before-4">die Angabe, ob eine gleichwertige Alternative im In- oder Ausland vorhanden ist;</dd>
<dt class="man-space-before-4">f. </dt>
<dd class="man-space-before-4">Beginn, Dauer und Ausmass des Versorgungsengpasses oder Lieferunterbruchs;</dd>
<dt class="man-space-before-4">g. </dt>
<dd class="man-space-before-4">Massnahmen, die im Zusammenhang mit dem Versorgungsengpass oder Lieferunterbruch getroffen wurden oder geplant sind.</dd>
</dl>
<p class="absatz man-space-before-4"><sup>2</sup> Die Meldung muss über das Informationssystem der Meldestelle (Heilmittelplattform) erfolgen. Kann die Heilmittelplattform aus technischen Gründen nicht genutzt werden, so müssen die Angaben auf einem anderen elektronischen Weg oder per Post übermittelt werden. </p>
</div></article><article id="art_4"><a name="a4"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_4"><b>Art. 4</b> Hinweise auf Versorgungsengpässe und Lieferunterbrüche</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Kantone, Spitäler, Ärzte und Ärztinnen, Apotheker und Apothekerinnen sowie Grosshändlerinnen und Grosshändler können die Meldestelle auf einen möglichen Versorgungsengpass oder Lieferunterbruch hinweisen. </p></div></article>
</div></section><section id="sec_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_3">3. Abschnitt:  Information und Empfehlungen</a>
</h1>
<div class="collapseable">
<article id="art_5"><a name="a5"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_5"><b>Art. 5</b> Information von Gesundheitsbehörden und Leistungserbringern</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4"><sup>1</sup> Die Meldestelle prüft die Meldungen und informiert die Gesundheitsbehörden der Kantone und des Bundes sowie die folgenden Leistungserbringer über Versorgungsengpässe und Lieferunterbrüche:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">Ärzte und Ärztinnen;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">Apotheker und Apothekerinnen;</dd>
<dt class="man-space-before-4">c. </dt>
<dd class="man-space-before-4">Hebammen;</dd>
<dt class="man-space-before-4">d. </dt>
<dd class="man-space-before-4">Personen, die auf Anordnung oder im Auftrag eines Arztes oder einer Ärztin Leistungen erbringen, und Organisationen, die solche Personen beschäftigen;</dd>
<dt class="man-space-before-4">e. </dt>
<dd class="man-space-before-4">Spitäler;</dd>
<dt class="man-space-before-4">f. </dt>
<dd class="man-space-before-4">Geburtshäuser;</dd>
<dt class="man-space-before-4">g. </dt>
<dd class="man-space-before-4">Pflegeheime;</dd>
<dt class="man-space-before-4">h. </dt>
<dd class="man-space-before-4">Einrichtungen, die der ambulanten Krankenpflege durch Ärzte und Ärztinnen dienen.</dd>
</dl>
<p class="absatz man-space-before-4"><sup>2</sup> Der Fachbereich Heilmittel informiert die Gesundheitsbehörden der Kantone und des Bundes sowie die betroffenen Leistungserbringer über alternative Wirkstoffe und Ersatzmöglichkeiten.</p>
<p class="absatz man-space-before-4"><sup>3</sup> Bei einem Hinweis nach Artikel 4 muss die Zulassungsinhaberin den Versorgungsengpass oder Lieferunterbruch bestätigen, bevor die Meldestelle darüber informiert.</p>
</div></article><article id="art_6"><a name="a6"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_6"><b>Art. 6</b> Empfehlungen</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4">Unterliegt ein Humanarzneimittel der Meldepflicht, so gibt der Fachbereich Heilmittel Empfehlungen ab:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">zur Beschränkung des Einsatzes von Humanarzneimitteln bei bestimmten Indikationen oder für bestimmte Patientengruppen;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">zur Einfuhr von Humanarzneimitteln, die in der Schweiz nicht zugelassen sind, aus einem Land mit vergleichbarer Arzneimittelkontrolle;</dd>
<dt class="man-space-before-4">c.  </dt>
<dd class="man-space-before-4">zur Genehmigung von Gesuchen der Zulassungsinhaberinnen um befristetes Inverkehrbringen identischer Humanarzneimittel mit ausländischer Aufmachung.</dd>
</dl>
</div></article>
</div></section><section id="sec_4"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_4">4. Abschnitt:  Datenschutz</a>
</h1>
<div class="collapseable">
<article id="art_7"><a name="a7"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_7"><b>Art. 7</b> Zugriff auf die Heilmittelplattform</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4">Zugriff auf die Heilmittelplattform haben:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">die Mitarbeiterinnen und Mitarbeiter der Meldestelle;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">der Datenschutzberater oder die Datenschutzberaterin des Bundesamts für wirtschaftliche Landesversorgung zur Erfüllung seiner beziehungsweise ihrer Kontrollfunktion;</dd>
<dt class="man-space-before-4">c. </dt>
<dd class="man-space-before-4">die für den Betrieb und den Unterhalt des Systems zuständigen Personen.</dd>
</dl>
</div></article><article id="art_8"><a name="a8"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_8"><b>Art. 8</b> Grundsätze der Datenbekanntgabe</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4" msg:wcstyle02-4="loose pPr/keepLines" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> Die Bekanntgabe von Daten der Heilmittelplattform ist nur zulässig an:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">die Gesundheitsbehörde eines Kantons oder des Bundes: zur Erfüllung ihres gesetzlichen Auftrags;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">Dritte, wenn diese die Daten ausschliesslich zu wissenschaftlichen Zwecken verwenden.</dd>
</dl>
<p class="absatz man-space-before-4"><sup>2</sup> Die Meldestelle muss die Daten vor der Bekanntgabe nach Absatz 1 Buchstabe b anonymisieren und sicherstellen, dass keine Rückschlüsse auf ein Geschäfts- oder Fabrikationsgeheimnis möglich sind.</p>
<p class="absatz man-space-before-4"><sup>3</sup> Die Empfänger und Empfängerinnen der Daten müssen mit organisatorischen und technischen Massnahmen sicherstellen, dass die Daten ausschliesslich für den angegebenen Zweck verwendet werden. Eine Weitergabe der Daten ist nur mit der Zustimmung der Meldestelle zulässig.</p>
</div></article><article id="art_9"><a name="a9"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_9"><b>Art. 9</b> Datenbekanntgabe an das Schweizerische Heilmittelinstitut</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4">Die Meldestelle gibt den Mitarbeiterinnen und Mitarbeitern des Schweizerischen Heilmittelinstituts, die folgenden Daten, die sie zur Bearbeitung von Gesuchen nach Artikel 9<i>b </i>Absatz 2 des Heilmittelgesetzes vom 15. Dezember 2000<sup><a href="#fn-d7e274" id="fnbck-d7e274">2</a></sup> (HMG) benötigen, im Abrufverfahren bekannt:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">Daten zu Versorgungsengpässen und Lieferunterbrüchen von Humanarzneimitteln, die der Meldepflicht unterliegen;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">Beurteilungen und Empfehlungen des Fachbereichs Heilmittel über die Versorgungslage;</dd>
<dt class="man-space-before-4">c. </dt>
<dd class="man-space-before-4">Informationen über Ersatzmöglichkeiten.</dd>
</dl>
<div class="footnotes"><p id="fn-d7e274"><sup><a href="#fnbck-d7e274">2</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2001/422" target="_blank">SR <b>812.21</b></a></p></div>
</div></article><article id="art_10"><a name="a10"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_10"><b>Art. 10</b> Datenbekanntgabe an die Helvecura</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4">Die Meldestelle gibt den Mitarbeiterinnen und Mitarbeitern der Selbsthilfeorganisation der Pflichtlagerhalter von Heilmitteln (Helvecura) die folgenden Daten, die sie für den Vollzug der ihnen im Zusammenhang mit der Pflichtlagerhaltung übertragenen Aufgaben benötigen, im Abrufverfahren bekannt:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">die Liefer- und Absatzdaten der auf der Heilmittelplattform erfassten Humanarzneimittel;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">die Kontaktangaben der Ansprechperson;</dd>
<dt class="man-space-before-4">c. </dt>
<dd class="man-space-before-4">statistische Angaben.</dd>
</dl>
</div></article><article id="art_11"><a name="a11"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_11"><b>Art. 11</b> Datenbekanntgabe durch Refdata und Helvecura</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4" msg:wcstyle02-4="loose pPr/keepLines" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> Die folgenden Stellen müssen der Meldestelle die nachstehenden Daten im Abrufverfahren bekanntgeben:</p>
<dl class="man-space-after-0">
<dt class="man-space-before-4">a. </dt>
<dd class="man-space-before-4">die Einrichtung nach Artikel 67 Absatz 3 HMG<sup><a href="#fn-d7e340" id="fnbck-d7e340">3</a></sup> (Refdata): sämtliche Daten der Einrichtung;</dd>
<dt class="man-space-before-4">b. </dt>
<dd class="man-space-before-4">die Helvecura: die Daten zu Ist- und Sollständen sowie zum Absatz von Humanarzneimitteln, die auf der Heilmittelplattform erfasst sind.</dd>
</dl>
<p class="absatz man-space-before-4"><sup>2</sup> Die Meldestelle darf nur Daten abrufen, wenn sie diese benötigt, um ihren gesetzlichen Auftrag zu erfüllen, insbesondere um die erforderlichen Vorbereitungs- und Interventionsmassnahmen zu treffen.</p>
<div class="footnotes"><p id="fn-d7e340"><sup><a href="#fnbck-d7e340">3</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2001/422" target="_blank">SR <b>812.21</b></a></p></div>
</div></article><article id="art_12"><a name="a12"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_12"><b>Art. 12</b> Aufbewahrungsdauer</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Die auf der Heilmittelplattform erfassten Daten werden ab dem Zeitpunkt der Erfassung mindestens zehn Jahre aufbewahrt und spätestens 15 Jahre nach der Erfassung vernichtet.</p></div></article><article id="art_13"><a name="a13"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_13"><b>Art. 13</b> Datensicherheit</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Der Fachbereich Heilmittel regelt in einem Datenbearbeitungsreglement die organisatorischen und technischen Massnahmen, um die unbefugte Bearbeitung der Daten zu verhindern und die automatische Protokollierung der Datenbearbeitung sicherzustellen.</p></div></article>
</div></section><section id="sec_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_5">5. Abschnitt:  Finanzierung</a>
</h1>
<div class="collapseable"><article id="art_14"><a name="a14"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_14"><b>Art. 14</b></a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Der Bund finanziert die Meldestelle.</p></div></article></div></section><section id="sec_6"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_6">6. Abschnitt:  Schlussbestimmungen</a>
</h1>
<div class="collapseable">
<article id="art_15"><a name="a15"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_15"><b>Art. 15</b> Vollzug</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Der Fachbereich Heilmittel vollzieht diese Verordnung.</p></div></article><article id="art_16"><a name="a16"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_16"><b>Art. 16</b> Änderung des Anhangs</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4">Das Eidgenössische Departement für Wirtschaft, Bildung und Forschung kann den Anhang nach Anhörung der Kantone, der beteiligten Wirtschaftskreise und der Gesundheitsinstitutionen ändern.</p></div></article><article id="art_17"><a name="a17"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_17"><b>Art. 17</b> Aufhebung anderer Erlasse</a>
</h6>
<div class="collapseable">
<p class="absatz man-space-before-4">Die Verordnung vom 12. August 2015<sup><a href="#fn-d7e410" id="fnbck-d7e410">4</a></sup> über die Meldestelle für lebenswichtige Humanarzneimittel wird aufgehoben.</p>
<div class="footnotes"><p id="fn-d7e410"><sup><a href="#fnbck-d7e410">4</a></sup><sup></sup> [<a href="https://fedlex.data.admin.ch/eli/oc/2015/544" target="_blank">AS <b>2015</b> 2895</a>; <b></b><a href="https://fedlex.data.admin.ch/eli/oc/2017/313" target="_blank"><b>2017</b> 3179 </a>Ziff. I 1; <b></b><a href="https://fedlex.data.admin.ch/eli/oc/2021/132" target="_blank"><b>2021</b> 132 </a>Anhang Ziff. 29; <b></b><a href="https://fedlex.data.admin.ch/eli/oc/2022/568" target="_blank"><b>2022 </b>568 </a>Anhang 2  Ziff. II 67; <b></b><a href="https://fedlex.data.admin.ch/eli/oc/2023/735" target="_blank"><b>2023</b> 735 </a>Anhang 2 Ziff. II 33, <a href="https://fedlex.data.admin.ch/eli/oc/2023/802" target="_blank">802</a>]</p></div>
</div></article><article id="art_18"><a name="a18"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_18"><b>Art. 18</b> Inkrafttreten</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4" msg:wcstyle02-4="loose pPr/keepLines" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Diese Verordnung tritt am 1. Juli 2025 in Kraft.</p></div></article>
</div></section></main><div id="annex"><section id="annex_u1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_u1">Anhang</a>
</h1>
<div class="collapseable">
<p class="titelanhtext">(Art. 2 Abs. 1)</p>
<section id="annex_u1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_u1/lvl_u1">Wirkstoffliste</a>
</h2>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">ATC-Code*</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Wirkstoff</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Bemerkung</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A07A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Intestinale Antiinfektiva</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A09AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Multienzyme (Lipase, Protease etc.)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A10A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Insuline und Analoga</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11CC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Colecalciferol (Vitamin D3)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11DA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Thiamin (Vitamin B1)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11DB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vitamin B1 in Kombination mit Vitamin B6 und/oder Vitamin B12</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11GA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ascorbinsäure (Vitamin C)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11HA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Pyridoxin (Vitamin B6)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A11HA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Riboflavin (Vitamin B2)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A12CC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Magnesiumsulfat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">A12CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Natriumselenit</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Phenprocoumon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Acenocoumarol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB01 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Heparin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">&gt; 100 IE/mL</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Antithrombin III</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dalteparin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Enoxaparin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Nadroparin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AB09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Danaparoid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AD02 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Alteplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dosierung &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AD04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Urokinase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AD11</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tenecteplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Argatroban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AE07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dabigatran</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AF01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Rivaroxaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Apixaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Edoxaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B01AX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fondaparinux</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B02AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tranexamsäure</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B02BD</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Blutgerinnungsfaktoren</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Albumin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Aminosäuren</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fettemulsionen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05BA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Kohlenhydrate</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen mit Glukose Konzentration ≥ 20 % w/V, Volumen &gt; 50 ml</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05BA10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lösungen zur parenteralen Ernährung, Kombinationen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">zentralvenös formulierte 3-Kammerbeutelsysteme</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05BB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Elektrolytlösungen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05DB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hypertone Lösungen zur Peritonealdialyse </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05XA14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dinatrium-1-glycerinphosphat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05XA31</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Elektrolyte, Kombinationen, inkl. reine Spurenelemente</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05XB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Alanyl-glutamin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05XC</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vitamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">B05ZB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hämofiltrate</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C01CA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Isoprenalin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Noradrenalin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dobutamin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Adrenalin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Furosemid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C07AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Metoprolol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">C07AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Labetalol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">D08AC52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Chlorhexidin, Kombinationen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Volumen &gt; 100 mL</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">D08AG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Iod-Povidon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Volumen &gt; 100 mL</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">D08AJ57 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Octenidin, Kombinationen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">D08AX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Isopropanol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">D08AX53</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Propanol, Kombinationen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">G02AD05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Sulproston</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">H01AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tetracosactid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">H01BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Desmopressin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Oxytocin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">H01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Carbetocin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Antibiotika zur systemischen Anwendung</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">ohne J01Z</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Antimykotika zur systemischen Anwendung</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J04A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Mittel zur Behandlung der Tuberkulose</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J05AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ganciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J05AB14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Valganciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J05AD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Foscarnet</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J05AH02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Oseltamivir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Humane Immunglobuline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">unspezifisch, extravaskulär</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Humane Immunglobuline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">unspezifisch, intravaskulär</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Anti-D-Immunglobulin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tetanus-Immunglobulin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Varizella/Zoster Immunglobulin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hepatitis B-Immunglobulin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J06BB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tollwut-Immunglobulin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">J07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Impfstoffe</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cyclophosphamid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Melphalan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ifosfamid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AA09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Bendamustin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Busulfan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Thiotepa</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Carmustin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Temozolomid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01AX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dacarbazin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Methotrexat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Mercaptopurin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tioguanin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cladribin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fludarabin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BB07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Nelarabin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cytarabin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fluorouracil</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Gemcitabin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BC06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Capecitabin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01BC07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Azacitidin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vincristin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vinorelbin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Etoposid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Paclitaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Docetaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CD04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cabazitaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Irinotecan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Alter ATC-Code</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01CX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Trabectedin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01DB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Doxorubicin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01DB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Epirubicin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01DC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Bleomycin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Imatinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Osimertinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dabrafenib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Trametinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EH02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Neratinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EL01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ibrutinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vandetanib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01EX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Midostaurin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Rituximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Inotuzumab ozogamicin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Daratumumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Trastuzumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Pertuzumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FD03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Trastuzumab emtansin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cetuximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Pembrolizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Durvalumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FF05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Atezolizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Bevacizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ramucirumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FX02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Gemtuzumab ozogamicin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ipilimumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Brentuximab vedotin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01FX07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Blinatumomab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cisplatin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Carboplatin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Oxaliplatin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XF01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tretinoin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Bortezomib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Carfilzomib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XH03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Panobinostat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XJ01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Vismodegib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hydroxycarbamid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XX23</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Mitotan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XX24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Pegaspargase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XX27</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Arsentrioxid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L01XX52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Venetoclax</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L02AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Goserelin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tamoxifen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L02BA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fulvestrant</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L03AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">BCG Impfstoff</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Antithymocytäres Immunglobulin (Kaninchen) </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AA13</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Leflunomid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Golimumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Basiliximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Azathioprin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">perorale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Methotrexat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">perorale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">L04AX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lenalidomid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M01AB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Diclofenac</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M01AB15</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ketorolac</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M01AE17</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dexketoprofen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M03AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Suxamethonium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M03AC04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Atracurium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Rocuronium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M03AC11</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Cisatracurium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">M03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dantrolen</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AB07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Desfluran</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Thiopental</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AH</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Opioidanästhetika</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AH06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Remifentanil</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Ketamin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lidocain</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Mepivacain</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N01BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Prilocain</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Morphin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hydromorphon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Oxycodon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AA08</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Dihydrocodein </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">exkl. Antitussiva</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Oxycodon und Naloxon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Pethidin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fentanyl</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Buprenorphin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Nalbuphin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AJ06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Codein und Paracetamol Kombination</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AJ13</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tramadol und Paracetamol Kombination</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tilidin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AX02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tramadol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02AX06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Tapentadol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Acetylsalicylsäure, inkl. Lysinacetylsalicylat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Metamizol, Natriumsalz</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N02BE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Paracetamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N03AX18</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lacosamid</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N05BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Diazepam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen und Tropfen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N05BA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lorazepam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Methadon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Levomethadon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">R03CC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Salbutamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">parenterale Formen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">R03CC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Hexoprenalin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">S01AD03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Aciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Augensalbe</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">S01JA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Fluorescein</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Augentropfen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AB14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Protamin</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AB35</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Sugammadex</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Sevelamer</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Lanthan III-carbonat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AE05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Eisen(III)-oxidhydroxid <br>Saccharose-Stärke-Komplex</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AE07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Calciumacetat </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V03AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Calciumfolinat (Folinsäure)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V08AA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Wasserlösliche nephrotrope hochosmolare Röntgenkontrastmittel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V08AB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Wasserlösliche nephrotrope niederosmolare Röntgenkontrastmittel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Bariumhaltige Röntgenkontrastmittel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">V08CA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3">Paramagnetische Kontrastmittel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">Ultraschallkontrastmittel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3"></p>
				</td>
			</tr>
			<tr>
				
				
				<td colspan="3"><dl class="man-space-after-0">
<dt class="man-space-after-3">* </dt>
<dd class="man-space-after-3">Der ATC-Code (Code des Wirkstoffs im «Anatomical Therapeutic Chemical Classification System») kann in der offiziellen englischen Fassung auf der Website des «Collaborating Centre for Drug Statistics Methodology» der Weltgesundheitsorganisation (WHO) unter folgender Adresse abgerufen werden: <a href="https://www.whocc.no/atc_ddd_index/" target="_blank">
							www.whocc.no
						</a> &gt; ATC/DDD Index. Die Zuteilung der Produkte folgt der ATC-Einteilung des Schweizerischen Heilmittelinstituts.</dd>
</dl></td>
			</tr>
			
			
		</table></div>
<p class="abstand1seite man-space-before-0"></p>
</div></section>
</div></section></div>
</div></body>
</html>
